Clinical Study for Endogenous Cushing's Syndrome


Now looking for volunteers to participate in SONICS, a clinical study for an investigational drug (COR-003).


About the Study

The purpose of the study is to test the safety and efficacy of COR-003 in the treatment of endogenous Cushing’s syndrome. This study is open-label, which means both the health providers and the participants in the study are aware of the drug or treatment being given. Information from this study will also help doctors learn more about COR-003 in treating endogenous Cushing’s syndrome.
The safety and efficacy of COR-003 for treatment of endogenous Cushing’s syndrome have not been established.
If you would like to be considered for the study, please visit .


Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now